Synexis® LLC a yau ta sanar da sabbin bayanai masu inganci daga wani bincike na baya-bayan nan da ke kimanta amfani da fasahar DHP™ a cikin yanayin asibiti an buga su a cikin fitowar yanzu na Jarida ta Amurka na Kula da Kamuwa (AJIC). Binciken na baya-bayan nan ya kimanta ingancin fasahar DHP™, ban da daidaitaccen tsabtace hannu, a rage cututtukan da aka samu a asibiti (HAIs) a cikin sashin kulawa mai zurfi (ICU) na asibitin cututtukan cututtukan cututtukan yara. A matsayin fasahar haɗin gwiwa don tsaftace muhalli, DHP™ ta ba da gudummawar rage HAI a cikin wannan saitin asibiti.

"Tsarin tsaftacewa da ka'idojin tsaftacewa bazai isa ba ga marasa lafiya marasa lafiya waɗanda ke da saukin kamuwa da HAI," in ji Dokta Mario Melgar, Daraktan Kula da Cututtuka da Kulawa.

An gudanar da binciken tsakanin Janairu 2019 da Nuwamba 2020 a ICU na yara (PICU) a Unidad Nacional de Oncología Pediátrica (UNOP), Cibiyar Bayar da Kai ga Yara masu fama da cutar kansa kuma abokin tarayya na duniya na babbar cibiyar cutar kansar yara a cikin US UNOP. Asibitin likitan yara masu gadaje 65 da ke Guatemala City, Guatemala. Kodayake suna bin duk ka'idodin CDC da ka'idoji don hana HAI, an ƙara fasahar DHP™ zuwa daidaitaccen tsaftace muhalli da tsabtace muhalli a cikin PICU don tantance tasirin sa akan ƙimar HAI.

“Wannan binciken yana nuna ƙimar fasahar DHP™. Na yi farin cikin ganin raguwar C. diff a cikin PICU namu," in ji Dokta Alicia Chang, Sashen Cututtuka. "Muna ci gaba da bin shawarwarin rigakafin da dabarun sarrafawa na CDC, kuma ƙari na DHP™ zuwa tsarin tsaftace muhallinmu ya taimaka inganta sakamakonmu."

Tsakanin 2019 da 2020, ƙari na DHP ™ zuwa daidaitaccen tsaftacewa ya haifar da raguwar 44.3% a cikin abin da ya faru na HAI (bambancin adadin abin da ya faru, IRD = -21.20, p=0.0277) a cikin PICU, gami da raguwar 76.4% a cikin Clostridioides-enteritis gastroitis. (IRD=-8.23, p=0.0482), idan aka kwatanta da lokacin kafin shigar DHP™. Bugu da ƙari, shari'a ɗaya ce kawai ta asibiti mai alaƙa da COVID-19 mai alaƙa da kamuwa da cutar huhu mara ciwon huhu ya faru a cikin PICU inda aka shigar da DHP™ idan aka kwatanta da wurin sarrafawa ba tare da DHP™ ba wanda ya sami karuwa a cikin cututtukan cututtukan numfashi marasa ciwon huhu. IRD=2.52; p=0.028). Wannan ya yi daidai da binciken da aka yi kwanan nan wanda ke nuna DHP ™ yana hana SARS-CoV-2 duka a cikin iska da saman sama.2,3 Gabaɗaya, fallasa ga DHP ™ ya haifar da raguwar 61.4% na kwangilar HAI yayin zamansu (OR= 0.386; p=0.029). Lamarin HAI bai canza sosai ba a wani sashe na asibitin da ba a shigar da DHP™ ba.

Eric Schlote, Shugaba na Synexis® ya ce "Cutar da aka samu a asibiti kamar COVID-19 mai alaƙa da cututtukan numfashi marasa ciwon huhu babbar barazana ce wacce tsaftace hannu ba zai iya kawar da ita gabaɗaya ba," in ji Eric Schlote, Shugaba na Synexis®. "Muna farin ciki cewa fasahar DHP ™ tana ci gaba da nuna tasiri a cikin saitunan asibiti kuma yana iya ba da wani kariya daga HAI da SARS-COV-2."

Marasa lafiya a cikin binciken sun kasance a cikin shekaru daga wata 1 zuwa shekaru 22, tare da matsakaicin shekarun shekaru 7.7. Yawancin (61%) marasa lafiya ne da cutar sankarar bargo, yayin da sauran an gano su da wasu nau'ikan ciwon daji, gami da sarcoma, blastoma da lymphoma. Waɗannan marasa lafiya suna cikin babban haɗari ga HAI saboda yanayin rashin lafiyarsu, fallasa ga na'urori da hanyoyin da za su iya cutar da su, da yanayin rashin lafiya.4 DHP™ Fasaha ta rage ƙimar HAI ba tare da haifar da wani mummunan al'amuran da suka shafi fallasa ga DHP™ ba.

Fasahar Synexis® tana tura DHP™ don tsaftace iska da saman. Kwayoyin DHP™ suna tafiya ko'ina cikin sararin samaniya don rage ƙwayoyin cuta, ƙwayoyin cuta, mold, wari da kwari da yawa. An ƙirƙira shi daga zafi na yanayi da iskar oxygen a zahiri a cikin muhalli, ana iya isar da DHP ™ yadda ya kamata a cikin wuraren da aka mamaye a matakan da ke ƙasa da ƙa'idodin aminci na iska wanda OSHA ya kafa, wanda ke ba da damar ci gaba da rage ƙananan ƙwayoyin cuta ba tare da dagula ayyukan al'ada da gudanawar aiki ba. iya tasiri gurɓataccen iska a cikin iska da saman a wuraren da ke da wuyar isa.

ABUBUWAN DA ZA KU GUDU DAGA WANNAN LABARI:

The study was conducted between January 2019 and November 2020 at the pediatric ICU (PICU) at Unidad Nacional de Oncología Pediátrica (UNOP), the National Referral Center for Children with Cancer and a global partner of a leading pediatric cancer institution in the U.
The retrospective analysis assessed the efficacy of DHP™ Technology, in addition to standard manual cleaning, in reducing hospital-acquired infections (HAIs) in the intensive care unit (ICU) of a pediatric oncology hospital.
Additionally, only one case of hospital-acquired COVID-19-associated non-pneumonia respiratory infection occurred in the PICU where DHP™ was installed compared to a control area without DHP™ which experienced an increase in hospital-acquired non-pneumonia respiratory infections (IRD=2.